These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18408131)

  • 1. Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis.
    Ogawa T; Veinot JP; Kuroski de Bold ML; Georgalis T; de Bold AJ
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2596-603. PubMed ID: 18408131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.
    Yuan Z; Nimata M; Okabe TA; Shioji K; Hasegawa K; Kita T; Kishimoto C
    Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1147-52. PubMed ID: 15879491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy.
    Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Exp Biol Med (Maywood); 2010 Nov; 235(11):1338-46. PubMed ID: 20876084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis.
    Nimata M; Kishimoto C; Yuan Z; Shioji K
    Mol Cell Biochem; 2004 Apr; 259(1-2):217-22. PubMed ID: 15124927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
    Sukumaran V; Veeraveedu PT; Gurusamy N; Lakshmanan AP; Yamaguchi K; Ma M; Suzuki K; Nagata M; Takagi R; Kodama M; Watanabe K
    Mol Cell Endocrinol; 2012 Apr; 351(2):208-19. PubMed ID: 22200414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase.
    Ma KK; Ogawa T; de Bold AJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):505-13. PubMed ID: 15081310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans.
    Meirovich YF; Veinot JP; de Bold ML; Haddad H; Davies RA; Masters RG; Hendry PJ; de Bold AJ
    J Heart Lung Transplant; 2008 Jan; 27(1):31-7. PubMed ID: 18187084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis.
    Liu X; Zhu X; Wang A; Fan H; Yuan H
    Int J Cardiol; 2009 Nov; 137(3):282-8. PubMed ID: 19896742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats.
    Nakamoto T; Harasawa H; Akimoto K; Hirata H; Kaneko H; Kaneko N; Sorimachi K
    Eur J Pharmacol; 2005 Dec; 528(1-3):43-51. PubMed ID: 16336959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis.
    Sukumaran V; Watanabe K; Veeraveedu PT; Gurusamy N; Ma M; Thandavarayan RA; Lakshmanan AP; Yamaguchi K; Suzuki K; Kodama M
    Int J Biol Sci; 2011 Feb; 7(2):154-67. PubMed ID: 21383952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans.
    Masters RG; Davies RA; Veinot JP; Hendry PJ; Smith SJ; de Bold AJ
    Circulation; 1999 Jul; 100(3):287-91. PubMed ID: 10411854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac secretion of atrial and brain natriuretic peptides in acute ischaemic heart failure in pigs: effect of angiotensin II receptor antagonism.
    Klinge R; Djøseland O; Karlberg BE; Hall C
    Clin Physiol; 1997 Jul; 17(4):389-400. PubMed ID: 19361150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The endocrine heart and inflammation].
    Ogawa T; de Bold AJ
    Medicina (B Aires); 2013; 73(6):562-6. PubMed ID: 24356270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression.
    Jia N; Okamoto H; Shimizu T; Chiba S; Matsui Y; Sugawara T; Akino M; Kitabatake A
    Hypertens Res; 2003 Sep; 26(9):737-42. PubMed ID: 14620930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical and neuroendocrine regulation of the endocrine heart.
    de Bold AJ; Bruneau BG; Kuroski de Bold ML
    Cardiovasc Res; 1996 Jan; 31(1):7-18. PubMed ID: 8849584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.
    Sukumaran V; Watanabe K; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
    Hypertens Res; 2010 Jul; 33(7):695-702. PubMed ID: 20535115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide from neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor.
    LaPointe MC; Sitkins JR
    Mol Endocrinol; 1993 Oct; 7(10):1284-96. PubMed ID: 8264660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncoordinated regulation of atrial natriuretic factor and brain natriuretic peptide in lipopolysaccharide-treated rats.
    Ogawa T; de Bold AJ
    Biomarkers; 2012 Mar; 17(2):140-9. PubMed ID: 22224641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.